Protalix BioTherapeutics (PLX) Gross Profit (2010 - 2026)
Protalix BioTherapeutics' Gross Profit came in at $12.13 million for Q2 2026, up 24.0% from $9.79 million a year earlier but down 59.0% from the prior quarter.
Powered by 
Analysis
Protalix BioTherapeutics (PLX) Gross Profit (2010 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Protalix BioTherapeutics reported Gross Profit of $55.79 million, up 56.5% year-over-year; for FY2025, it was $25.75 million, down 11.4% from FY2024.
- Gross Profit carries a five-year compound annual growth rate of -13.1% (FY2020 to FY2025).
- Going back by year, Gross Profit was $29.08 million in FY2024 (-31.6%), $42.51 million in FY2023 (+51.6%), $28.05 million in FY2022 (+27.5%) and $22 million in FY2021 (-57.7%).
- The five-year range for quarterly Gross Profit is $1.15 million (Q1 2024) to $29.62 million (Q1 2026).
- Year-over-year, Gross Profit increased in five of the last seven quarters, with growth averaging 146.0%.
- The fastest year-over-year change in Gross Profit over five years came in Q4 2024 (growth of 779.3%), and the weakest in Q2 2024 (a decline of 86.1%).
- Business Quant data shows PLX's Gross Profit at $29.62 million (Q1 2026), $4.5 million (Q4 2025) and $9.53 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | Protalix BioTherapeutics | 207.16 Mn | 55.78 Mn | 12.13 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 12.13 Mn |
| Mar 31, 2026 | 29.62 Mn |
| Dec 31, 2025 | 4.50 Mn |
| Sep 30, 2025 | 9.53 Mn |
| Jun 30, 2025 | 9.79 Mn |
| Mar 31, 2025 | 1.93 Mn |
| Dec 31, 2024 | 14.33 Mn |
| Sep 30, 2024 | 9.58 Mn |
| Jun 30, 2024 | 4.02 Mn |
| Mar 31, 2024 | 1.15 Mn |
| Dec 31, 2023 | 1.63 Mn |
| Sep 30, 2023 | 5.45 Mn |
| Jun 30, 2023 | 28.93 Mn |
| Mar 31, 2023 | 6.50 Mn |
| Dec 31, 2022 | 6.22 Mn |
| Sep 30, 2022 | 7.11 Mn |
| Jun 30, 2022 | 4.67 Mn |
| Mar 31, 2022 | 10.05 Mn |
| Dec 31, 2021 | 5.40 Mn |
| Sep 30, 2021 | 8.35 Mn |
API Access
Protalix BioTherapeutics Gross Profit API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-profit&ticker=PLX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-profit", "ticker": "PLX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-profit&ticker=PLX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();